top of page

NMDAR Encephalitis: A Possible Pathophysiological Model For Pediatric Neuropsychiatric Disorders

Mycophenolate mofetil in paediatric autoimmune or immune‐mediated diseases

Neuroimmune disorders of the central nervous system in children in the molecular era

In the Clinic-Autoimmune Encephalitis: Persistent Cognitive, Neuropsychological Deficits After Anti-NMDAR Encephalitis Require Therapy, Study Suggests

Anti-N-methyl-d-aspartate receptor encephalitis in children: Incidence and experience in Hong Kong

Initial clinical presentation of young children with N-methyl-d-aspartate receptor encephalitis

Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitis

Anti-N-methyl-d-aspartate receptor encephalitis in children: Incidence and experience in Hong Kong

Severe GABAA receptor encephalitis without seizures: A paediatric case successfully treated with early immunomodulation

Anti-NMDA receptor encephalitis in Māori and Pacific Island children in New Zealand

(D2 antibody) Autoimmune encephalitis in children: clinical phenomenology, therapeutics, and emerging challenges

Autoimmune encephalitis in children: clinical phenomenology, therapeutics, and emerging challenges

The neuropsychological profile of children with basal ganglia encephalitis: a case series

Anti-NMDAr Encephalitis Appearing as a New-Onset Psychosis: Disease Course in Children

anti-NMDAR survey of 151 Pediatric Neurologists: how to treat

Anti-N-Methyl-D-Aspartate Receptor Encephalitis in Children and Adolescents

Gait Disturbance as the Presenting Symptom in Young Children With Anti-NMDA Receptor Encephalitis

Acute Pediatric Encephalitis Neuroimaging: Single-Institution Series as Part of the California Encephalitis Project

The growing spectrum of antibody-associated inflammatory brain diseases in children

Status epilepticus in paediatrics: a retrospective study and review of the literature

Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease

Paediatric AE clinical features, laboratory investigations & outcomes with/without anitbodies to CNS known autoantigens

Paediatric AEs: clinical features: in patients w/ or w/o antibodies to known CNS autoantigens


Our website is not a substitute for independent professional medical advice. Nothing contained on our website is intended to be used as medical advice. No content is intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for your own health professional's advice. Although THE INTERNATIONAL AUTOIMMUNE ENCEPHALITIS SOCIETY  provides a great deal of information about AUTOIMMUNE ENCEPHALITIS, all content is provided for informational purposes only. The International Autoimmune Encephalitis Society  cannot provide medical advice.

IAE Society is a Delaware Charitable Nonprofit and a registered 501(c)(3) organization.

© 2019 International Autoimmune Encephalitis Society- All Rights Reserved.

  • Facebook Social Icon
  • Twitter Social Icon
  • YouTube Social  Icon
bottom of page